![]() ANI Pharmaceuticals ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A. | ![]() Olainfarm Olainfarm manufactures and distributes chemical and pharmaceutical products primarily in Latvia. | ![]() Merus Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients. | |
Founding Date | Founding Date 1996 | Founding Date 1972 | Founding Date 2003 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Baudette, US HQ Oakville, CA Baudette, US | Locations Olaine, LV HQ | Locations Utrecht, NL HQ Cambridge, US |
Employees | Employees 33813% increase | Employees 2,191 | Employees 1893% increase |
Valuation ($) | Valuation ($) 514.4 m | Valuation ($) 150.2 m | Valuation ($) N/A |
Alexa Website Rank | Alexa Website Rank 150691 | Alexa Website Rank 110995 | Alexa Website Rank 563795 |
Employee Rating | Employee Rating 3.5 | Employee Rating 4.4 | Employee Rating 4.2 |
Financial | |||
Revenue (est.) | Revenue (est.) $208.5m (FY, 2020) | Revenue (est.) €124.3m (FY, 2018) | Revenue (est.) N/A |
Cost of goods | Cost of goods $87.2m (FY, 2020) | Cost of goods (€45.6m) (FY, 2018) | Cost of goods N/A |
Gross profit | Gross profit $121.3m (FY, 2020) | Gross profit €81.1m (FY, 2018) | Gross profit N/A |
Net income | Net income ($22.5m) (FY, 2020) | Net income €10.7m (FY, 2018) | Net income N/A |
Olainfarm manufactures and distributes chemical and pharmaceutical products primarily in Latvia.
View companyMerus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.
View company